Literature DB >> 11779715

Abl: mechanisms of regulation and activation.

Jodi M Smith1, Bruce J Mayer.   

Abstract

The Abl non-receptor tyrosine kinase has been implicated in a wide variety of cellular processes, yet its function and regulation remain poorly understood. Abl has resisted complete understanding not due to lack of interest, but due to the complexity of its overall structure and the corresponding complexity and diversity of its biological activities in the cell. Although Abl consists of many familiar modules with well-understood activities, the ways in which these modules interact are manifold and defy simple categorization. A picture now emerges in which Abl can be potentially regulated in many ways: by phosphorylation, by intramolecular interaction, by interaction with a variety of other proteins, by subcellular localization. Far from being a simple on-off switch, it appears that Abl is better understood as existing in a complex and dynamic equilibrium of states, an equilibrium that can be affected by many signaling inputs. In this review we will discuss the various ways in which the kinase activity of Abl can be regulated; other recent reviews have discussed the larger issue of possible biological roles of Abl (1-3).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779715     DOI: 10.2741/a767

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  c-Abl mediates high NaCl-induced phosphorylation and activation of the transcription factor TonEBP/OREBP.

Authors:  Morgan Gallazzini; Ming-Jiun Yu; Ruwan Gunaratne; Maurice B Burg; Joan D Ferraris
Journal:  FASEB J       Date:  2010-06-28       Impact factor: 5.191

Review 2.  Degradation of activated protein kinases by ubiquitination.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

3.  Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.

Authors:  Syed Z Imam; Qing Zhou; Ayako Yamamoto; Anthony J Valente; Syed F Ali; Mona Bains; James L Roberts; Philipp J Kahle; Robert A Clark; Senlin Li
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

4.  Role of zinc metallothionein-3 (ZnMt3) in epidermal growth factor (EGF)-induced c-Abl protein activation and actin polymerization in cultured astrocytes.

Authors:  Sook-Jeong Lee; Kyung-Sook Cho; Ha Na Kim; Hyun-Jae Kim; Jae-Young Koh
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

5.  Enteropathogenic Escherichia coli use redundant tyrosine kinases to form actin pedestals.

Authors:  Alyson Swimm; Bettina Bommarius; Yue Li; David Cheng; Patrick Reeves; Melanie Sherman; Darren Veach; William Bornmann; Daniel Kalman
Journal:  Mol Biol Cell       Date:  2004-05-21       Impact factor: 4.138

6.  Altered subcellular distribution of c-Abl in Alzheimer's disease.

Authors:  Zheng Jing; John Caltagarone; Robert Bowser
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 7.  Involvement of crk adapter proteins in regulation of lymphoid cell functions.

Authors:  Sigal Gelkop; Yael Babichev; Rachel Kalifa; Ami Tamir; Noah Isakov
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

8.  Productive replication of Ebola virus is regulated by the c-Abl1 tyrosine kinase.

Authors:  Mayra García; Arik Cooper; Wei Shi; William Bornmann; Ricardo Carrion; Daniel Kalman; Gary J Nabel
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

9.  Phosphoinositide, phosphopeptide and pyridone interactions of the Abl SH2 domain.

Authors:  Etienne Tokonzaba; Daniel G S Capelluto; Tatiana G Kutateladze; Michael Overduin
Journal:  Chem Biol Drug Des       Date:  2006-03       Impact factor: 2.817

10.  Allosteric regulation of autoinhibition and activation of c-Abl.

Authors:  Yonglan Liu; Mingzhen Zhang; Chung-Jung Tsai; Hyunbum Jang; Ruth Nussinov
Journal:  Comput Struct Biotechnol J       Date:  2022-08-11       Impact factor: 6.155

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.